Stockscreener 앱 받기
3.075
0.81%
-0.025
시간 외 거래:
3.03
-0.045
-1.46%
전일 마감가:
$3.10
열려 있는:
$3.14
하루 거래량:
21,271
Relative Volume:
0.31
시가총액:
$4.42M
수익:
$6.63M
순이익/손실:
$-4.06M
주가수익비율:
-0.557
EPS:
-5.5206
순현금흐름:
$-4.20M
1주 성능:
+0.16%
1개월 성능:
-27.65%
6개월 성능:
-39.24%
1년 성능:
-45.98%
1일 변동 폭
$3.03
$3.20
1주일 범위
$2.88
$3.30
52주 변동 폭
$2.88
$5.76
Bio Key International Inc Stock (BKYI) Company Profile
명칭
Bio Key International Inc
전화
(732) 359-1100
주소
101 CRAWFORDS CORNER RD, HOLMDEL
Compare BKYI vs MSFT, PLTR, ORCL, CRWD, FTNT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BKYI
Bio Key International Inc
|
3.075 | 4.45M | 6.63M | -4.06M | -4.20M | -5.5206 |
MSFT
Microsoft Corp
|
513.53 | 3.57T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
186.29 | 418.04B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
150.85 | 409.23B | 67.36B | 17.31B | -23.69B | 5.8248 |
CRWD
Crowdstrike Holdings Inc
|
218.40 | 193.82B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
166.00 | 110.64B | 7.11B | 1.95B | 2.44B | 2.5883 |
Bio Key International Inc Stock (BKYI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-26 | 업그레이드 | Maxim Group | Hold → Buy |
Bio Key International Inc 주식(BKYI)의 최신 뉴스
BIO-key (BKYI) Q2 2026 Earnings Call Transcript - The Globe and Mail
KALA BIO: Q2 Earnings Snapshot - AOL.com
BIO-key International (BKYI)Conferencia de resultados del T2 de 2026: margen bruto del 87 %, objetivo de rentabilidad para el segundo semestre - TradingKey
BIO-key International (BKYI) Teleconferência de Resultados do T2 de 2026: Margem Bruta de 87%, Meta de Lucratividade para o Segundo Semestre - TradingKey
BIO-key International Inc (BKYI) (Q2 2026) Earnings Call Highlig - GuruFocus
BIO-key International Reports Narrower Loss for Q2 FY26; Revenue up 13% - AlphaStreet
BIO-key International (BKYI) asks investors to approve 1.24M-share warrant issuance - Stock Titan
BIO-key International | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
BKYI Q2 FY2026 earnings call - finance.biggo.com
BIO-key International (BKYI) Q2 2026 Earnings Call: 87 % Bruttomarge, Profitabilitätsziel für das zweite Halbjahr - TradingKey
BIO-key International (BKYI) Q2 2026 Earnings Call: 87% Gross Margin, Second-Half Profitability Target - TradingKey
BIO-key International Releases Q2 2026 Financial Results - AlphaStreet
BIO-key International Q2 2026 Earnings Call Transcript - MarketBeat
BKYI: Record gross margin and strong EMEA growth drive improved results and positive H2 outlook - TradingView
Earnings call transcript: BIO-key beats q2 2026 EPS but misses revenue as shares fall - Investing.com Australia
BKYI: Q2 2026 delivered strong margin gains and revenue growth, with profitability targeted for H2 - TradingView
BIO-key International Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Form 8K BIO-Key International Inc For: 14 August By Investing.com - Investing.com Australia
BIO-key International, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BIO-key Q2 Revenue Rises 13% as Net Loss Narrows 51% - Quiver Quantitative
BIO Key International Q2’26: Revenues up 13% to $1.92M; net loss narrowed 51% - TradingView
BIO-key International (NASDAQ: BKYI) grows Q2 sales and cuts loss sharply - Stock Titan
BIO-key Q2 Loss Narrows to $576,852 Despite Cash Reserve Decline - Minichart
BKYI Looks 49.6% Overvalued on GF Value™ - GuruFocus
BKYI: Q2'26 revenue up 13%, net loss down 51%, with strong EMEA growth and improved margins - TradingView
BIO-key Q2 revenue up 13%, net loss down 51% on margin expansion - scanx.trade
BIO-key reports Q2 revenue up 13%, narrows net loss by 51% - Investing.com Australia
Form 8K BIO-Key International Inc For: 13 August By Investing.com - Investing.com Nigeria
Bio-key International reduces warrant exercise price in agreement with investor By Investing.com - Investing.com
BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 Revenues Reflecting Strength with Government, Defense, and Financial Sector Customers Globally; Call Tomorrow at 10am ET - The Manila Times
BIO-key Raises $2.51 Million via Warrant Exercise; Issues New Warrants, Hires Maxim Group - TradingView
BIO KEY INTERNATIONAL INC 2026: Revenue $1.92M, EPS ($0.56) — 10-Q Summary - TradingView
BIO-key’s Bottom Line Improves 51% on 13% Rise in Q2 - GlobeNewswire
BIO-key International (BKYI) secures $2.51M and issues 1.24M new warrants in financing - Stock Titan
BIO-key (BKYI) grows revenue to $4.1M but warns on going concern, liquidity - Stock Titan
BIO-key International | 10-Q: Q2 2026 Earnings Report - Moomoo
BIO-key International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BIO-key issues unregistered warrants for 1,236,668 shares in private placement deal - Bitget
BIO-key secures $2.5M through warrant exercise agreement By Investing.com - Investing.com UK
Stock Market Today: Dow Futures Slip, S&P 500 Gains as Trump Says US Is 'Only Semi-Negotiating' With Iran—T. Rowe Price, Plug Power, BIO-Key in Focus - Sahm
BIO-key secures $2.5M through warrant exercise agreement - Investing.com
Bio-Key International Enters Into $2.5 Million Warrant Inducement Transaction - TradingView
BIO-key International Enters into $2.5 Million Warrant Inducement Transaction - The Manila Times
BIO-key Investor Agrees to Exercise 618,334 Warrants at $4.06 - Stock Titan
Stock Market Today: Dow, S&P 500 Futures Fell as Trump Says US Is 'Only Semi-Negotiating' With Iran—T. Ro - Benzinga
BIO-Key Scores Portuguese National Security Deal - TradingView
BKYI Looks 72.2% Overvalued on GF Value™ - GuruFocus
BIO-key wins contract with Portuguese national security agency to bolster digital identity security - Bitget
Portuguese National Security Agency Selects BIO-key and Visualforma to Strengthen Identity Security - The Manila Times
BIO-key International and Visualforma Win Contract to Strengthen Digital Identity Security for Portuguese National Security Agency - Quiver Quantitative
Portugal Security Agency Selects Fingerprint Identity Tools - Stock Titan
Bio Key International Inc (BKYI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.96%
자본화:
|
볼륨(24시간):